Skip to main content

and
  1. No Access

    Article

    Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter

    The sodium/iodide symporter (NIS) has been recognized as an attractive target for radioiodine-mediated cancer gene therapy. In this study we investigated the role of human NIS for cellular uptake of the high ...

    T. Petrich, H.-J. Helmeke, G. Meyer in European Journal of Nuclear Medicine and M… (2002)

  2. No Access

    Article

    Aberrations of chromosomes 5 and 8 as recurrent cytogenetic events in anaplastic carcinoma of the thyroid as detected by fluorescence in situ hybridisation and comparative genomic hybridisation

    Comparative genomic hybridisation (CGH) is a technique which identifies gains and losses of DNA sequence copy number in tumours. We used CGH to search for genetic changes in one of the most aggressive malignan...

    L. Wilkens, D. Benten, J. Tchinda, G. Brabant, E. Pötter, H. Dralle in Virchows Archiv (2000)

  3. No Access

    Article

    A versatile chondrogenic rat calvaria cell line R-tTA-24 that permits tetracycline-regulated gene expression

    The clonal rat calvaria cell line RCJ3.1C5.18 (RCJ) undergoes chondrogenic differentiation after long-term culture post confluence. To allow flexible genetic manipulation, a tetracycline-regulated gene express...

    C. Bergwitz, T. Wendlandt, E. Pötter, I. Glomb, K. Gras in Histochemistry and Cell Biology (2000)

  4. No Access

    Article

    Expression of wild-type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany

    Introduction: Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy. Although the clinical course is usually rather benign, a subset of tumors is more aggressive. The ret/PTC oncogene was found...

    B. Mayr, E. Pötter, P. Goretzki, J. Rüschoff in Langenbeck's Archives of Surgery (1999)

  5. No Access

    Article

    Expression of Ret/PTC1, -2, -3, -Δ3 and -4 in German papillary thyroid carcinoma

    Ret/PTC oncogene has been described with a frequency of 2.5-30% in papillary thyroid carcinomas. We examined the expression of ret/PTC in 99 German papillary thyroid carcinomas, including two recently describe...

    B Mayr, E Pötter, P Goretzki, J Rüschoff, W Dietmaier in British Journal of Cancer (1998)